About Komal Bhattar
Komal's passion for the stock market and financial analysis led her to pursue investment research as a career. Her fundamental approach to analyzing stocks helps investors identify the best investment opportunities.
She earned a bachelor's degree in accounting and finance from St. Xavier’s College, and she is currently pursuing a graduate degree in Chartered Accountancy.
Recent Articles By Komal Bhattar
3 Stocks to Add to Your Portfolio Before It's Too Late
The Fed’s determination to bring inflation under control with aggressive rate hikes has led to a stock market sell-off. However, this could be an opportunity to add shares of financially robust companies trading below their intrinsic values. Thus, one could consider adding fundamentally sound stocks Microsoft (MSFT), HCA Healthcare (HCA), and APA Corporation (APA) to their portfolios now. Read on…
4 Software Stocks That Are Better Buys Than Adobe Right Now
Rapid digital transformation across sectors is expected to drive the prospects of the software market. Software giant Adobe (ADBE) recently announced its plans to acquire Figma in an expensive deal. Amid this, we think fundamentally strong software stocks, Synopsys (SNPS), Rimini Street (RMNI), Progress Software (PRGS), and Mitek Systems (MITK), could be better investments than ADBE now. Read on…
2 Cruise Ship Stocks That Should Be Avoided at All Costs
The cruise ship industry suffered huge losses amid the pandemic. Moreover, surging inflation and the Fed’s aggressive rate hikes seem to be weighing on cruise ship stocks. Hence, it might be best to avoid fundamentally bleak stocks, Royal Caribbean (RCL) and Carnival Corporation (CCL) now. Read on…
5 Stocks to Sell During This Bear Market
Raging inflation and the Fed’s hawkish stance have kept the stock market under tremendous pressure. Moreover, a third-consecutive rate hike last week has caused the major benchmark indexes to plunge. So, we think fundamentally weak stocks Las Vegas Sands (LVS), Roblox Corporation (RBLX), Carnival Corporation (CCL), Marathon Digital Holdings (MARA), and ContextLogic (WISH) could be best avoided during this bear market. Read on…
2 No-Brainer Stocks to Buy if You Have the Money
The stock market witnessed a sell-off last week after the Fed launched another significant rate hike to fight inflation. And analysts predict the S&P 500 to decline further. Thus, it could be wise to invest in rock-solid stocks Cisco Systems (CSCO) and TravelCenters of America (TA) to survive market uncertainties. Keep reading…
3 Biotech Stocks to Sell Before the End of This Year
The biotech industry witnessed solid growth during the pandemic. However, that seems to be fading away amid the receding pandemic and growing recession concerns. So, it could be wise to avoid biotech stocks Ginkgo Bioworks Holdings (DNA), GeoVax Labs (GOVX), and Aditxt (ADTX), given their bleak fundamentals. Read on…
3 Stocks That’ll Help You Score Big No Matter What Happens Next
The Fed launched another 75-basis-point rate hike this week and signaled it would keep increasing rates until inflation is under control. The consecutive rate hikes are raising recession concerns. We think fundamentally solid stocks Bristol-Myers (BMY), AT&T (T), and Gilead Sciences (GILD), which have the potential to deliver steady returns despite market uncertainties, could be ideal buys now. Keep reading…
2 Stocks That Could Help Hedge Your Bets in 2022
Despite the Fed’s aggressive interest rate hikes, inflation continues to take a toll on the economy. With growing recession fears, it could be best to invest in Walmart (WMT) and Coca-Cola (KO), given their solid fundamentals. Also, these stocks have an impressive dividend-paying history and could help cushion your portfolio in 2022. Read on…
4 Stocks to Buy With Market-Beating Potential
The stock market has been under pressure amid the high inflation and the Fed’s hawkish tilt. The Fed launched another 75 basis-point rate hike on Wednesday and indicated that it would keep increasing rates to bring down inflation to the target level. Thus, we think fundamentally solid stocks AbbVie (ABBV), Bristol-Myers (BMY), Cigna Corporation (CI), and Mosaic Company (MOS) which have the potential to outperform the market in the near term, could be ideal buys now. Keep reading…